Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Joyce

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|January 23, 2019
Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at riskAnna Weiss, Samantha Grossmith, Danielle Cutts, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2012
Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?Atbin Djamshidian, Sean S O'Sullivan, Yanosh Sanotsky, et al.
Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.
Bjpsych Open|October 9, 2018
Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosisBettina Balint, Helen Killaspy, Louise Marston, et al.
Trials|March 17, 2018
The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trialTil Wykes, Eileen Joyce, Tjasa Velikonja, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Nature Communications|July 5, 2020
A unified connectomic target for deep brain stimulation in obsessive-compulsive disorderNingfei Li, Juan Carlos Baldermann, Astrid Kibleur, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|January 23, 2019
Customized breast cancer risk assessment in an ambulatory clinic: a portal for identifying women at riskAnna Weiss, Samantha Grossmith, Danielle Cutts, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2012
Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?Atbin Djamshidian, Sean S O'Sullivan, Yanosh Sanotsky, et al.
Brain, Behavior, and Immunity|November 8, 2020
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatmentCarl R Krynicki, Paola Dazzan, Carmine M Pariante, et al.
Bjpsych Open|October 9, 2018
Development and clinimetric assessment of a nurse-administered screening tool for movement disorders in psychosisBettina Balint, Helen Killaspy, Louise Marston, et al.
Trials|March 17, 2018
The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trialTil Wykes, Eileen Joyce, Tjasa Velikonja, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Nature Communications|July 5, 2020
A unified connectomic target for deep brain stimulation in obsessive-compulsive disorderNingfei Li, Juan Carlos Baldermann, Astrid Kibleur, et al.
Brain, Behavior, and Immunity|July 9, 2023
Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityParis Alexandros Lalousis, Lianne Schmaal, Stephen J Wood, et al.
Translational Psychiatry|September 18, 2023
Network analysis of inflammation and symptoms in recent onset schizophrenia and the influence of minocycline during a clinical trialSarah E Herniman, Stephen J Wood, Golam Khandaker, et al.
The Lancet. Psychiatry|October 17, 2018
The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trialBill Deakin, John Suckling, Thomas R E Barnes, et al.
Pageof 5